Katarina Bartuma

444 total citations
7 papers, 210 citations indexed

About

Katarina Bartuma is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Ophthalmology. According to data from OpenAlex, Katarina Bartuma has authored 7 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Ophthalmology. Recurrent topics in Katarina Bartuma's work include Genetic factors in colorectal cancer (3 papers), Ocular Oncology and Treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Katarina Bartuma is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Ocular Oncology and Treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Katarina Bartuma collaborates with scholars based in Sweden, Denmark and United States. Katarina Bartuma's co-authors include Mef Nilbert, Susanne Malander, Zohreh Ketabi, Inge Bernstein, Susanne Holck, Erik Björck, Henrik Grönberg, Stefan Holm, Niklas Pal and Charlotta All‐Ericsson and has published in prestigious journals such as British Journal of Ophthalmology, Gynecologic Oncology and Frontiers in Oncology.

In The Last Decade

Katarina Bartuma

7 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarina Bartuma Sweden 7 81 69 54 53 51 7 210
Joanne Comerford United States 5 12 0.1× 39 0.6× 57 1.1× 93 1.8× 53 1.0× 5 176
Renée Perrier Canada 7 8 0.1× 42 0.6× 51 0.9× 29 0.5× 57 1.1× 19 192
Nicholas Hearle United Kingdom 7 38 0.5× 69 1.0× 4 0.1× 84 1.6× 48 0.9× 8 206
Angela Burleigh Canada 7 5 0.1× 56 0.8× 78 1.4× 32 0.6× 52 1.0× 12 246
E. Tronczyńska Poland 4 10 0.1× 55 0.8× 5 0.1× 25 0.5× 21 0.4× 4 171
Benjamin Goode United States 4 10 0.1× 21 0.3× 23 0.4× 45 0.8× 85 1.7× 4 210
Tomomi Aoi Japan 7 83 1.0× 18 0.3× 21 0.4× 73 1.4× 10 228
Debasis Chakrabarti United States 7 90 1.1× 21 0.3× 1 0.0× 85 1.6× 55 1.1× 15 279
Casper Reijnen Netherlands 10 2 0.0× 41 0.6× 228 4.2× 43 0.8× 75 1.5× 27 420
Dominique Stoppa‐Lyonnet France 8 2 0.0× 40 0.6× 28 0.5× 46 0.9× 140 2.7× 17 257

Countries citing papers authored by Katarina Bartuma

Since Specialization
Citations

This map shows the geographic impact of Katarina Bartuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Bartuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Bartuma more than expected).

Fields of papers citing papers by Katarina Bartuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Bartuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Bartuma. The network helps show where Katarina Bartuma may publish in the future.

Co-authorship network of co-authors of Katarina Bartuma

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Bartuma. A scholar is included among the top collaborators of Katarina Bartuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Bartuma. Katarina Bartuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Kvanta, Anders, Emma Lardner, Jill Fielding-Wells, et al.. (2020). Nuclear expression of BAP-1 in transvitreal incisional biopsies and subsequent enucleation of eyes with posterior choroidal melanoma. British Journal of Ophthalmology. 105(4). 582–586. 14 indexed citations
2.
Filì, Maria, Eric Trocmé, Louise Bergman, et al.. (2019). Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm. British Journal of Ophthalmology. 104(1). 26–32. 34 indexed citations
3.
Bartuma, Katarina, Sofia Westbom-Fremer, Anna Måsbäck, et al.. (2017). Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma. Frontiers in Oncology. 7. 109–109. 20 indexed citations
4.
Bartuma, Katarina, Mev Dominguez–Valentin, Katja Harbst, et al.. (2014). Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome. Familial Cancer. 13(4). 537–545. 14 indexed citations
5.
Bartuma, Katarina, et al.. (2013). A 10‐year experience of outcome in chemotherapy‐treated hereditary retinoblastoma. Acta Ophthalmologica. 92(5). 404–411. 37 indexed citations
6.
Bartuma, Katarina, Mef Nilbert, & Christina Carlsson. (2012). Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations. Hereditary Cancer in Clinical Practice. 10(1). 6–6. 13 indexed citations
7.
Ketabi, Zohreh, Katarina Bartuma, Inge Bernstein, et al.. (2011). Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors. Gynecologic Oncology. 121(3). 462–465. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026